This week’s topics include a study on ICD programming to reduce inappropriate therapy and mortality, a clinical review of diagnosing and managing supraventricular tachycardia, the Global Burden of Disease Study 2010, and more.
A drug-eluting stent is successfully implanted after an acute inferior MI in a fit 70-year-old man. What do you do for the bystander disease detected at the LAD/D1 junction?
The use of drug-eluting stents (DES) in patients with acute myocardial infarction (AMI) has recently generated concern. In two meta-analyses (De Luca et al and Kaleson et al) , the use of early-generation DES resulted in a lower risk of repeat revascularization compared with bare-metal stents (BMS) in patients with AMI, but the DES group had a 2-fold increased…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
John Ryan interviews Elizabeth Bradley about the hospital management strategies that can reduce 30-day risk-standardized mortality rates for acute myocardial infarction.
Two mortality-risk calculators – one for patients with acute MI and another for those with heart failure – are now available for free at www.mortalityscore.org. The calculators are based on risk models produced by our research group at Yale for the Center for Medicare and Medicaid Services (CMS). The models are derived from Medicare administrative-claims…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
This week’s topics include acute MI and potassium levels, cardiac arrest during long-distance running, the anticoagulant idrabiotaparinux, and managing hypertension in the very elderly.
